Skip to content

Petco Health and Wellness

US · WOOF #3589 by market cap Listed 2021
2.20 -0.03 -1.13%
Live - 5344 symbols - heartbeat 178s ago · 2026-10-08 09:57
Pre-market 2.18 -1.80%
After-hours 2.21 -0.36%
Overnight 2.22 0.00%
Market cap
628.69M
P/B
0.52
EPS
0.03
Reader sentiment Are you bullish or bearish on WOOF?

Anonymous reader poll. Unscientific, not investment advice.

Valuation each multiple against its own 5-year range

P/B ratio 0.53 Cheap vs history 8th percentile
5-year average 2.15 · #8 of 41 in Specialty Retail
P/E ratio 22.20 In line with history 49th percentile
5-year average 7.06 · forward 12.97 · #23 of 32 in Specialty Retail
P/S ratio 0.11 Cheap vs history 4th percentile
5-year average 0.54 · forward 0.11 · #9 of 48 in Specialty Retail

Vs. peers Specialty Retail

Company Market cap P/E (TTM) P/B Div yield
Petco Health and Wellness (WOOF) 628.69M 21.95 0.52 0.00%
Williams-Sonoma (WSM) 28.15B 24.51 13.15 1.19%
Caseys General Stores (CASY) 23.74B 30.94 5.80 0.37%
Ulta Beauty (ULTA) 23.48B 20.00 8.88 0.00%
Best Buy (BBY) 18.03B 14.30 5.66 4.44%
Tractor Supply (TSCO) 16.97B 16.96 6.45 2.89%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★★★ Fair value4.02 Economic moatNone UncertaintyHigh

Trading 82.9% below Morningstar's fair value estimate.

Fair value

Petco Health and Wellness Co Inc receives a 5-star quantitative star rating, indicating our belief that this share class offers a compelling opportunity for investors. The stock currently trades at a 45% discount to our quantitative fair value estimate of $4.02 per share; however, caution is warranted due to this estimate's high uncertainty rating.

The company's valuation metrics strengthen our estimated fair value. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 193.0%, which falls in the top 20% compared with peers globally. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are cheap.

The firm's profitability is an additional encouraging factor. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. The firm's earnings yield of 10.2%, a core component of profitability, sits in the top 20% compared with global peers. This suggests that it is generating substantial earnings relative to its share price, which further promotes our favorable price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has been a laggard relative to the broader universe over the past year. This underperformance makes the stock appear cheap, which portends a buying opportunity in light of other contributors to our model.

Economic moat

With its quantitative economic moat rating of none, this business is unlikely to consistently outearn its cost of capital without structural protection from competition. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-10-08 09:57:20 · For reference only, not investment advice and not tailored to your situation.